Thursday, October 12, 2006

Tacere Scores Seed Financing

San Jose-based Tacere Therapeutics has received an undisclosed amount of seed financing, the firm said today. The funding came from Hokkaido Venture Capital. Tacere is developing treatments for serious infectious disease, and is initially focused on the treatment of Hepatitis C. More information »